Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001280022 | SCV001638737 | likely benign | Wilson disease | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451637 | SCV002616606 | likely benign | Inborn genetic diseases | 2020-09-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001280022 | SCV004836245 | likely benign | Wilson disease | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001280022 | SCV001467168 | uncertain significance | Wilson disease | 2020-04-15 | no assertion criteria provided | clinical testing |